Bank Pictet & Cie Europe AG Increases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank Pictet & Cie Europe AG increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 190,969 shares of the medical equipment provider’s stock after purchasing an additional 883 shares during the period. Intuitive Surgical accounts for 2.2% of Bank Pictet & Cie Europe AG’s portfolio, making the stock its 9th largest position. Bank Pictet & Cie Europe AG owned approximately 0.05% of Intuitive Surgical worth $99,678,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the 4th quarter valued at $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the 3rd quarter valued at $38,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock worth $3,587,582 in the last three months. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Up 0.7 %

Shares of NASDAQ ISRG opened at $595.55 on Friday. The stock has a market capitalization of $212.12 billion, a price-to-earnings ratio of 92.91, a PEG ratio of 5.67 and a beta of 1.39. The stock’s fifty day simple moving average is $558.58 and its 200 day simple moving average is $518.00. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Analyst Ratings Changes

ISRG has been the topic of several recent analyst reports. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. Leerink Partners lifted their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Barclays lifted their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Finally, Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.